Data & Technology

Quris’s system can help predict clinical safety, AI firm notes

Software firm merges with PharmaLex Group

A sit-down with members of the Deloitte team, who discuss the findings of the company’s yearly research and development report

Merger with Phlexglobal expands provider’s technological capabilities

Integrated system intends to accelerate enrollment by strengthening relationship between hub patient services and providers

Partnership looks to ensure that chargebacks for suppliers are as accurate as possible

Companies to focus on market access strategies

Deal helps expands software company’s labeling capabilities in clinical trial, med device and pharma spaces

Protagen, BioAnalytix and GeneWerk merger set to target biopharma, C&GT sectors

Partnership enhances CBM’s manufacturing capabilities in C&GT space

A prescription for making the pharma supply chain more resilient, reliable and disruption-proof

The new parent company will expand security, monitoring and remedial action for pharma shipments

Parties will collaborate in enhancing chronic disease care therapies

ABC’s new acquisition, FirstView Financial, addresses underpayment of pharmacies, as well as patient assistance programs

Collaboration focuses on continuing to improve time to therapy and medication adherence for patients, while effectively optimizing clinical data

The biggest areas of adjustment in patient support brought on by changes in consumer and physician behavior

The Discovery Centre will be powered by AI technology, robotics, among other features

Transaction is anticipated to further Novo’s research in the field of RNAi therapeutics

Four trends shaping healthcare in 2022 and beyond

How AI-powered support automation can solve the data problem in clinical trial management

A conversation with Justin Hoss, technology leader for life sciences, KPMG

AI-driven strategies for pharma brand marketing teams to help bridge the gap from data intelligence to execution

Ongoing strides in data mining, data analytics, modeling and simulation are opening up new and more definitive opportunities to apply data-driven insights to improve everything from upstream drug discovery and clinical trials, to the downstream go-to-market strategy and post-patent lifecycle management

ConvergeHEALTH Safety intended to automate pharmacovigilance case processing

Outlining the key digital trends accelerated by the transformed healthcare landscape in 2021—and their impact on pharma commercialization strategies going forward

Respondents: Pharmacies are still lagging in the compliance requirements that will be in effect in November 2023

Acquisition reportedly increases AI accessibility across life sciences organizations

As companies seek interoperability across their organizations, a joint approach to medical information and local pharmacovigilance may deliver future benefits

The pandemic has accelerated the adoption of enterprise resource planning in pharma supply chain management, as the recent US rise of one “technology enabler” attests

Using AI and data engineering insight, purchase offers customers potential to shorten clinical trials and accelerate time to commercialization